SIFI Overview
- Year Founded
-
1935
- Status
-
Acquired/Merged
- Employees
-
500
- Latest Deal Type
-
M&A
- Financing Rounds
-
8
- Investments
-
2
SIFI General Information
Description
Operator of an ophthalmic company based in Aci Sant'Antonio, Italy. The company offers a full-cycle, integrated business model, including research, development, manufacturing and marketing of pharmaceutical specialties and surgical and medical devices. Is focus lies on the development, production and marketing of pharmaceutical treatments, diagnostic instruments and surgical equipment for eye care for the ocular pathologies, nutraceuticals and ophthalmic cosmetics, enabling patients to avail responsive treatment for diverse eye care conditions.
Contact Information
Website
www.sifigroup.com(Operating Subsidiary)
Corporate Office
- Via Ercole Patti 36
- Lavinaio
- 95025 Aci Sant'Antonio
- Italy
Corporate Office
- Via Ercole Patti 36
- Lavinaio
- 95025 Aci Sant'Antonio
- Italy
SIFI Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SIFI Patents
SIFI Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026171779-A1 | Compounds to prevent and/or treat the fibrosis related to the glaucoma filtering surgery | Pending | 11-Feb-2025 | ||
| WO-2026038136-A1 | Lens for ophthalmic use for varying the depth of field | Pending | 12-Aug-2024 | ||
| EP-4356906-A1 | Composizione nutraceutica ad effetto neuroprotettivo per il trattamento del glaucoma | Pending | 20-Oct-2022 | ||
| EP-4356906-A8 | Nutraceutical composition with neuroprotective effect for the treatment of glaucoma | Pending | 20-Oct-2022 | ||
| EP-4514318-A1 | Microemulsion pharmaceutical composition for treatment of disorders of the anterior segment of the eye | Pending | 29-Apr-2022 | A61K9/1075 |
SIFI Signals
SIFI Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
SIFI Investments (2)
SIFI’s most recent deal was a Joint Venture with AffaMed Therapeutics & SIFI (Joint Venture) for . The deal was made on 31-Mar-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AffaMed Therapeutics & SIFI (Joint Venture) | 31-Mar-2021 | Joint Venture | Surgical Devices | ||
| Gifrer (Ophthalmic Business) | 04-Jul-2019 | Buyout/LBO | Buildings and Property |
SIFI Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Confortplus | Mantova, Italy | 2015 |
SIFI FAQs
-
When was SIFI founded?
SIFI was founded in 1935.
-
Where is SIFI headquartered?
SIFI is headquartered in Aci Sant'Antonio, Italy.
-
What is the size of SIFI?
SIFI has 500 total employees.
-
What industry is SIFI in?
SIFI’s primary industry is Pharmaceuticals.
-
Is SIFI a private or public company?
SIFI is a Private company.
-
What is the current valuation of SIFI?
The current valuation of SIFI is .
-
What is SIFI’s current revenue?
The current revenue for SIFI is .
-
How much funding has SIFI raised over time?
SIFI has raised $40.6M.
-
Who are SIFI’s investors?
21 Invest has invested in SIFI.
-
When was SIFI acquired?
SIFI was acquired on 02-Sep-2025.
-
Who acquired SIFI?
SIFI was acquired by Faes Farma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process